Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
posTErs<br />
Posters<br />
Page 430 PROgRammE & ExhibiTiOn guidE • WCB 2012<br />
abS. numbER<br />
> Planned TURP prior to LDR prostate brachytherapy does not cause<br />
incontinence<br />
E. Chadwick (United Kingdom), S. Javed, R.W. Laing, S.E.M. Langley PO-225<br />
> Incorporating Edema in prostate seed implant dosimetry using<br />
a clinically-informed Edema model<br />
D. Liu (Canada), T. Monajemi, R. Sloboda PO-226<br />
> C4 markers for MRI-based prostate brachytherapy<br />
S. Frank (USA), T. Madden, D.A. Swanson, K. Martirosyan, R. Uthamanthil,<br />
J. Stafford, M. Gagea, T.J. Pugh, R. Kudchadker, M.J. Johansen PO-227<br />
> Prospective evaluation of pharmacologic penile rehabilitation<br />
following prostate brachytherapy<br />
T.J. Pugh (USA), D.A. Swanson, R.J. Kudchadker, T.L. Bruno,<br />
M.F. Munsell, S.J. Frank PO-228<br />
> Acute and chronic toxicity associated with three high-dose-rate<br />
brachytherapy monotherapy schedules<br />
J. Dilworth (USA), H. Ye, M. Ghilezan, M. Wallace, C. Shah, D. Krauss,<br />
G. Gustafson, A. Martinez PO-229<br />
> Single fraction HDR brachytherapy and EBRT for prostate cancer:<br />
an analysis of health related quality of life<br />
J. Malik (United Kingdom), C. Arthur, R. Swindell, P. Mandall,<br />
A. Choudhury, A. Tran, J. Livsey, P. Elliot, J. Logue, J. Wylie PO-230<br />
> Low dose rate brachytherapy is an excellent treatment option<br />
for young men with localised prostate cancer<br />
R. Laing (United Kingdom), E. Chadwick, S. Javed, S.E.M. Langley PO-231<br />
> Are urethral toxicities correlated with dose after interstitial<br />
HDR boost brachytherapy for prostate cancer?<br />
R. Broksch (Germany), F.A. Siebert, N. Brüske, B. Kimmig, R. Galalae PO-232<br />
Posters<br />
> Intensity modulated high-dose-rate brachytherapy as monotherapy<br />
for clinically localized prostate cancer<br />
N. Tselis (Germany), D. Baltas, U.W. Tunn, T. Buhleier, T. Martin,<br />
N. Milickovic, S. Papaioannou, H. Ackermann, N. Zamboglou PO-233<br />
posTEr: GynAEColoGy<br />
abS. numbER<br />
> Dose optimization of intra-vaginal brachytherapy using different<br />
multi-channel applicators<br />
H. Kuo, K. Mehta, R. Yaparpalvi (USA), L. Hong, A. Wu, D. Mynampati,<br />
W. Bodner, M. Garg, S. Kalnicki PO-234<br />
> Clinical outcome and dosimetric parameters of MRI-guided<br />
brachytherapy in cervical cancer patients<br />
C.N. Nomden (The Netherlands), A.A.C. de Leeuw, J.M. Roesink,<br />
J.H.A. Tersteeg, M.A. Moerland, I.M. Jürgenliemk-Schulz PO-235<br />
> 3D image based vs. point based dosimetry for cervical cancer:<br />
early outcome analysis<br />
N. Kannan, H. Kim, C. Houser, S. Beriwal (USA) PO-236<br />
> Dosimetric effects of rectal filling on vaginal cylinder brachytherapy<br />
S. Sabater (Spain), I. Andres, V. de la Vara, M.J. Muñoz, E. Jimenez,<br />
M.V. Carrizo, A. Martos, R. Berenguer, A. Nuñez, M. Arenas PO-237<br />
> Dosimetric comparison of optimisation methods for multichannel<br />
intracavitary vaginal brachytherapy<br />
C. Lapuz (Australia), C. Dempsey, P. O’Brien PO-238<br />
> The role of vaginal brachytherapy in the treatment of stage I<br />
papillary serous or clear cell endometrial cancer<br />
B. Barney (USA), I. Petersen, M. Haddock PO-239<br />
> Daily HDR brachytherapy in the postoperative setting of endometrial<br />
carcinoma<br />
A. Rovirosa (Spain), I. Valduvieco, A. Herreros, C. Bautista, I. Romera,<br />
I. Rios, M. Arenas, A. Biete PO-240<br />
WCB 2012 • PROgRammE & ExhibiTiOn guidE Page 431<br />
posTErs<br />
WCB
Change language